Who are Atmobiosciences's investors?

Atmobiosciences's investors include Breakthrough Victoria.

Where is Atmobiosciences headquartered?

Atmobiosciences is headquartered in New York City, US.

Atmobiosciences

New York City, US · 1 known investors

Find your way into Atmobiosciences

Your email: who you already know at Atmobiosciences, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Atmobiosciences team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.

Biotech Healthtech Medical Devices

Founders & leadership

Mal HebblewhiteCEO

Investors · 1

Breakthrough Victorialisted by Breakthrough VictoriaMelbourne

How we know: Breakthrough Victoria's portfolio page · Not right? Tell us

Frequently asked questions

What does Atmobiosciences do?: Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.
Who are Atmobiosciences's investors?: Atmobiosciences's investors include Breakthrough Victoria.
Where is Atmobiosciences headquartered?: Atmobiosciences is headquartered in New York City, US.